Work

Phase I/II Trial of Bortezomib + CHOP-Rituximab in Diffuse Large B Cell (DLBCL) and Mantle Cell Lymphoma (MCL): Phase I Results.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.491.491

Authors: John P. Leonard, Richard R. Furman, Ying-Kuen K. Cheung, Eric J. Feldman, Hearn J. Cho, Julie M. Vose, Gwen Nichols, Patricia W. Glynn, Maureen A. Joyce, Jamie Ketas, Jia Ruan, John Carew, Ruben Niesvizky, Ann LaCasce, Amy Chadburn, Ethel Cesarman, Morton Coleman

Institutions: NewYork–Presbyterian Hospital, Cornell University, Weill Cornell Medical Center, Herbert Irving Comprehensive Cancer Center, Columbia University, University of Nebraska Medical Center, Dana-Farber Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558411656

FWCI: 3.238

Cites:

Cited by: 41

Related to: 10